British study shows Clinuvel drug effective on DNA of UV-damaged skin
Clinuvel Pharmaceuticals Ltd (ASX:CUV) has announced positive final results from a British-conducted…
Clinuvel Pharmaceuticals Limited (ASX:CUV)
About Clinuvel Pharmaceuticals Limited
Key Information
CUV In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 05/07/2024 | Notification of cessation of securities - CUV | 13.51KB | 861 |
| 05/07/2024 | Price Sensitive PS Afamelanotide Assists DNA Repair Response Following UVR | 90.5KB | 33K |
| 28/06/2024 | Price Sensitive PS CLINUVEL extends Managing Director Employment Agreement | 91.02KB | 4.1K |
| 28/06/2024 | Change of Company Secretary | 57.78KB | 311 |
| 24/06/2024 | SCENESSE European Orphan Drug Designation for VP | 83.03KB | 4.2K |
| 18/06/2024 | Price Sensitive PS afamelanotide in fair-skinned Parkinsons patients | 96.54KB | 6.4K |
| 11/06/2024 | CLINUVEL Newsletter III - June 2024 | 330.48KB | 10K |
| 05/06/2024 | Update - Notification of buy-back - CUV | 15.7KB | 674 |